Webinar presentation: 2021 Therapeutic Goods Advertising Code, 17 February 2022
Presentation on guiding advertisers through the new Therapeutic Goods Advertising Code 2021.
Disclaimer
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Kate Kaylock, Rowena Love - Therapeutic Goods Administration
- Presented at: Online webinar
- Presentation date: Thursday 17 February 2022
- Presentation summary: Guiding advertisers through the new Therapeutic Goods Advertising Code 2021. It will highlight the changes to the 2021 Code compared to the 2018 Code and explain compliance obligations for advertisers during the six-month transition period and from 1 July 2022 when the 2018 Code will be repealed.
-
Presentation: 2021 Therapeutic Goods Advertising Code, 17 February 2022 (pdf,663kb)
Related content
-
Sharing information about the safety, quality and performance of medical devices - lunchtime session
We are seeking feedback on a proposal to improve information sharing about the safety, quality and performance of medical devices. -
Sharing information about the safety, quality and performance of medical devices - evening session
We are seeking feedback on a proposal to improve information sharing about the safety, quality and performance of medical devices.